ADC Therapeutics (ADCT) Operating Expenses (2023 - 2026)
ADC Therapeutics' (ADCT) quarterly Operating Expenses came in at $46.1 million in Q1 2026, down 10.49% year-on-year from $51.5 million in Q1 2025, and down 2.74% quarter-over-quarter from $47.4 million in Q3 2025.
ADC Therapeutics (ADCT) Operating Expenses (2023 - 2026) Analysis & Trends
ADC Therapeutics has disclosed Operating Expenses across 4 years of filings, most recently posting $46.1 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -67.40 Mn |
| 10 | ADC Therapeutics | 167.24 Mn | -63.76 Mn | 7.33 Mn | 46.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.10 Mn |
| Sep 30, 2025 | 47.40 Mn |
| Jun 30, 2025 | 62.99 Mn |
| Mar 31, 2025 | 51.50 Mn |
| Sep 30, 2024 | 54.03 Mn |
| Jun 30, 2024 | 46.45 Mn |
| Mar 31, 2024 | 51.67 Mn |
| Sep 30, 2023 | 50.64 Mn |
| Jun 30, 2023 | 58.93 Mn |